Literature DB >> 2080717

Frequency distributions of tetracycline-based measurements: implications for the interpretation of bone formation indices in the absence of double-labeled surfaces.

J Foldes1, M S Shih, A M Parfitt.   

Abstract

The frequency distributions of mineral apposition rate (MAR) and mineralizing surface (MS), measured separately on the intracortical, endocortical, and cancellous surfaces in 46 normal subjects and 79 patients with postmenopausal osteoporosis, indicated that MAR has a finite lower limit of 0.3 mu/day (uncorrected for section obliquity) but that MS has no finite lower limit. We conclude that in the absence of labels MAR, and indices derived from it, must be treated as missing values, but that MS and indices with MS in the numerator should be allowed to take values of zero. To avoid infinite values for indices with MS in the denominator, we propose that osteoid mineralization rate (the reciprocal of mineralization lag time) and osteoblast vigor (the reciprocal of formation period) be used instead. For surfaces with genuine single labels (SL) but no double labels, we propose that MS is calculated as SL/2 and that for MAR either the lower limit of 0.3 or the mean measured value from other surfaces be used for calculating derived indices.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2080717     DOI: 10.1002/jbmr.5650051010

Source DB:  PubMed          Journal:  J Bone Miner Res        ISSN: 0884-0431            Impact factor:   6.741


  28 in total

1.  Compromised osseous healing of dental extraction sites in zoledronic acid-treated dogs.

Authors:  M R Allen; D J Kubek; D B Burr; S L Ruggiero; T-M G Chu
Journal:  Osteoporos Int       Date:  2010-05-11       Impact factor: 4.507

2.  Mechanical property and tissue mineral density differences among severely suppressed bone turnover (SSBT) patients, osteoporotic patients, and normal subjects.

Authors:  Crystal K Tjhia; Clarita V Odvina; D Sudhaker Rao; Susan M Stover; Xiang Wang; David P Fyhrie
Journal:  Bone       Date:  2011-09-18       Impact factor: 4.398

3.  The effect of local simvastatin delivery strategies on mandibular bone formation in vivo.

Authors:  Yeonju Lee; Marian J Schmid; David B Marx; Mark W Beatty; Diane M Cullen; Melissa E Collins; Richard A Reinhardt
Journal:  Biomaterials       Date:  2008-02-05       Impact factor: 12.479

4.  Histomorphometric interpretation of bone biopsies for the evaluation of osteoporosis treatment.

Authors:  Juliet E Compston
Journal:  Bonekey Rep       Date:  2012-04-04

5.  Basal bone phenotype and increased anabolic responses to intermittent parathyroid hormone in healthy male COX-2 knockout mice.

Authors:  Manshan Xu; Shilpa Choudhary; Olga Voznesensky; Qi Gao; Douglas Adams; Vilmaris Diaz-Doran; Qian Wu; David Goltzman; Lawrence G Raisz; Carol C Pilbeam
Journal:  Bone       Date:  2010-05-13       Impact factor: 4.398

Review 6.  Issues in modern bone histomorphometry.

Authors:  R R Recker; D B Kimmel; D Dempster; R S Weinstein; T J Wronski; D B Burr
Journal:  Bone       Date:  2011-07-23       Impact factor: 4.398

7.  Ovariectomy stimulates and bisphosphonates inhibit intracortical remodeling in the mouse mandible.

Authors:  D J Kubek; D B Burr; M R Allen
Journal:  Orthod Craniofac Res       Date:  2010-11       Impact factor: 1.826

8.  Comparison of bone formation rates measured by radiocalcium kinetics and double-tetracycline labeling in maintenance dialysis patients.

Authors:  M Cochran; M Cochran; A Neville; E A Marshall
Journal:  Calcif Tissue Int       Date:  1994-05       Impact factor: 4.333

9.  Cortical and trabecular bone benefits of mechanical loading are maintained long term in mice independent of ovariectomy.

Authors:  Stuart J Warden; Matthew R Galley; Andrea L Hurd; Jeffrey S Richard; Lydia A George; Elizabeth A Guildenbecher; Rick G Barker; Robyn K Fuchs
Journal:  J Bone Miner Res       Date:  2014       Impact factor: 6.741

10.  Bone structure and remodelling in stroke patients: early effects of zoledronate.

Authors:  Kenneth E S Poole; Shobna Vedi; Irene Debiram; Collette Rose; Jon Power; Nigel Loveridge; Elizabeth A Warburton; Jonathan Reeve; Juliet Compston
Journal:  Bone       Date:  2008-12-11       Impact factor: 4.398

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.